Compara a los mejores médicos de Quimioterapia para el cáncer de mama y precios en Alemania. Encuentra aquí tu mejor opción.
Seleccionaremos los mejores médicos según tus necesidades y presupuesto.
Revisado médicamente por Fahad Mawlood
Editor médico y Científico de datosMejores médicos
2
Alemania
Reseñas
14000+
De pacientes reales
Compara precios de Quimioterapia para el cáncer de mama entre los principales países
Toca un país para ver los mejores médicos y precios
Recibe planes de tratamiento personalizados gratuitos y elige la mejor opción. Sin compromiso · Sin pagos por nuestros servicios
El Dr. Bernd Hertenstein cuenta con 32 años de experiencia en oncología, especializándose en quimioterapia para el cáncer de mama en la Clínica Bremen-Mitte.
El Prof. Jorg Groticke dirige el Centro de Oncología del Hospital Bremen Mitte, especializándose en neoplasias hematológicas y tumores gastrointestinales.
Elegir una clínica en el extranjero puede ser estresante. En Bookimed, con más de 800K pacientes ayudados, entendemos sus preocupaciones. Sabemos cómo encontrar médicos de confianza, las mejores opciones calidad-precio y soluciones incluso para casos complejos. Estamos aquí para guiarle en cada paso de su viaje médico.
Yan Matsiivskiy
Jefe del Equipo de coordinadores médicos
Más de 4300+ acompañamientos de pacientes
3 años en Bookimed
1022 pacientes de Germany han encontrado a su médico con nosotros este mes
Cuestionario de 2 minutos
Cuéntanos tu objetivo, presupuesto, y tiempo estimado
Coincidencia humana + IA
Nuestro algoritmo busca coincidencias, el coordinador verifica la compatibilidad
Tus opciones listas
Compara precios, paquetes, fechas. Chatea con tu coordinador
¿Demasiadas opciones?
Guiando tu tratamiento
Coordinadores personales con formación médica
| Clasificación | Médico | experiencia | Buena opción para | Qué los distingue | Ubicación de la clínica | Consulta |
|---|---|---|---|---|---|---|
| #1 | Quimioterapia para el cáncer de mama | Se especializa en tratamientos avanzados para el cáncer de mama, incluyendo trasplantes de médula ósea. Colaborador en numerosas publicaciones de oncología. | Alemania | Precio a consultar | ||
| #2 | Neoplasias hematológicas | Médico Jefe del Centro de Oncología y Hematología con más de 30 años de experiencia. Miembro de sociedades oncológicas alemanas líderes y ponente sobre terapias innovadoras. | Alemania | de $650 |
Top oncologists for breast cancer chemotherapy in Germany include board-certified specialists at accredited cancer centers. These experts typically hold German Cancer Society certifications and participate in multidisciplinary tumor boards. Leading doctors like Dr. Viola Fox and Dr. Séverine Iborra integrate molecular diagnostics with personalized treatment protocols.
Bookimed Expert Insight: Data shows that choosing a dually qualified specialist often improves the patient journey. For example, Dr. Séverine Iborra in Solingen is a specialist in both gynecology and oncology. This combination allows one doctor to manage surgical diagnostics and chemotherapy protocols concurrently. Patients at these centers benefit from consolidated care without needing separate visits for imaging and treatment.
Patient Consensus: Patients emphasize that receiving a clear roadmap of the chemotherapy cycles and side-effect management is vital. Many found that large university hospitals offer the best coordination for pathology and imaging under one roof. They also noted that having English-speaking staff significantly reduces the stress of undergoing intensive treatment abroad.
Qualified breast cancer doctors in Germany must hold Facharzt certification in oncology or gynecology. You can verify their expertise by checking for associations with centers accredited by the German Cancer Society. Top specialists often lead multidisciplinary tumor boards to personalize chemotherapy protocols and manage complex cases.
Bookimed Expert Insight: German oncology structures prioritize interdisciplinary leadership. For example, Dr. Séverine Iborra at Solingen leads a specialized Senology center, while Prof. Boris Pfaffenbach heads an entire oncology department. This dual focus means your chemotherapy plan is overseen by a specialist who also manages the broader clinical department and participates in integrated tumor boards.
Patient Consensus: Patients note that well-qualified doctors often provide a written protocol immediately after the first consultation. They feel more confident when they see a multidisciplinary team, including surgeons and oncologists, collaborating on their specific case details. Many were relieved to find that reputable specialists encourage second opinions to confirm the best treatment path.
International patients can obtain independent second opinions from breast cancer specialists at leading German university hospitals. Board-certified oncologists provide these reviews through multidisciplinary tumor boards. They evaluate pathology reports and imaging to verify diagnoses. Remote consultations via video are frequently available for international cases.
Bookimed Expert Insight: Data shows that choosing specialists in academic centers like Bremen-Mitte or Solingen provides access to extensive research backgrounds. For instance, Prof. Boris Pfaffenbach has authored over 130 publications. This academic focus ensures patients receive opinions based on the latest clinical trials and innovative protocols. This is particularly valuable for rare or aggressive breast cancer subtypes.
Patient Consensus: Patients note that providing complete records is essential for a meaningful review. Many were relieved when specialists confirmed their current plans or refined treatment steps. They found that major clinics provide detailed written reports that are easy to share with local doctors.
German breast cancer specialists use both neoadjuvant and adjuvant chemotherapy based on individual tumor characteristics. Neoadjuvant therapy before surgery is favored for aggressive or large tumors to shrink them. This approach often allows for breast-conserving surgery instead of a full mastectomy.
Bookimed Expert Insight: German clinics like Academic Hospital Solingen and Nordwest Clinic utilize multidisciplinary boards to decide the chemotherapy sequence. Dr. Séverine Iborra at Solingen leads a dedicated breast clinic where molecular diagnostics guide these decisions. Data shows that German professors, such as Dr. Boris Pfaffenbach, often integrate extensive research into personalized protocols. This ensures the timing of chemotherapy aligns with the latest clinical findings for each specific cancer subtype.
Patient Consensus: Patients note that the treatment sequence feels like a collaborative decision between oncologists and surgeons. They appreciate that doctors explain how shrinking the tumor first can lead to less invasive surgery. Many felt reassured when their medical team adjusted the plan based on how the tumor responded to initial doses.
Breast cancer doctors in Germany use targeted therapies like HER2-inhibitors and CDK4/6 inhibitors alongside chemotherapy. Experts such as Dr. Viola Fox at Medical Center Solingen apply molecular diagnostics to select precise antibody-drug conjugates. This personalized approach often includes immunotherapy and specialized interventional radiology to improve outcomes.
Bookimed Expert Insight: German oncology centers stand out by staffing dual-qualified specialists. For instance, Dr. Viola Fox holds certifications in both oncology and genetics. This allows clinics to integrate molecular tumor boards directly into the treatment planning phase. Patients benefit from real-time genomic insights that determine if they qualify for the latest clinical trials.
Patient Consensus: Patients find that treatment plans are strictly driven by detailed pathology results like HER2 and BRCA status. Many note the frequency of neoadjuvant therapy, which combines targeted drugs with chemotherapy to shrink tumors before surgery. They emphasize feeling reassured by the highly protocolized nature of German cancer centers.